Correlation Between Ironwood Pharmaceuticals and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Ironwood Pharmaceuticals and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ironwood Pharmaceuticals and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ironwood Pharmaceuticals and Neurocrine Biosciences, you can compare the effects of market volatilities on Ironwood Pharmaceuticals and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ironwood Pharmaceuticals with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ironwood Pharmaceuticals and Neurocrine Biosciences.
Diversification Opportunities for Ironwood Pharmaceuticals and Neurocrine Biosciences
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ironwood and Neurocrine is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Ironwood Pharmaceuticals and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Ironwood Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ironwood Pharmaceuticals are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Ironwood Pharmaceuticals i.e., Ironwood Pharmaceuticals and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Ironwood Pharmaceuticals and Neurocrine Biosciences
Given the investment horizon of 90 days Ironwood Pharmaceuticals is expected to generate 1.21 times less return on investment than Neurocrine Biosciences. In addition to that, Ironwood Pharmaceuticals is 1.29 times more volatile than Neurocrine Biosciences. It trades about 0.03 of its total potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.05 per unit of volatility. If you would invest 13,774 in Neurocrine Biosciences on February 2, 2024 and sell it today you would earn a total of 209.00 from holding Neurocrine Biosciences or generate 1.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Ironwood Pharmaceuticals vs. Neurocrine Biosciences
Performance |
Timeline |
Ironwood Pharmaceuticals |
Neurocrine Biosciences |
Ironwood Pharmaceuticals and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ironwood Pharmaceuticals and Neurocrine Biosciences
The main advantage of trading using opposite Ironwood Pharmaceuticals and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ironwood Pharmaceuticals position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.Ironwood Pharmaceuticals vs. Pulmatrix | Ironwood Pharmaceuticals vs. Adial Pharmaceuticals | Ironwood Pharmaceuticals vs. Jaguar Animal Health | Ironwood Pharmaceuticals vs. Acasti Pharma |
Neurocrine Biosciences vs. Pulmatrix | Neurocrine Biosciences vs. Adial Pharmaceuticals | Neurocrine Biosciences vs. Jaguar Animal Health | Neurocrine Biosciences vs. Acasti Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |